Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Authors :: Colleoni M
Luo W
Karlsson P
Chirgwin J
Aebi S
Jerusalem G
Neven P
Hitre E
Graas MP
Simoncini E
Kamby C
Thompson A
Loibl S
Gavilá J
Kuroi K
Marth C
Müller B
O'Reilly S
Di Lauro V
Gombos A
Ruhstaller T
Burstein H
Ribi K
Bernhard J
Viale G
Maibach R
Rabaglio-Poretti M
Gelber RD
Coates AS
Di Leo A
Regan MM
Goldhirsch A
SOLE Investigators
Source :: The Lancet. Oncology, r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA, instname
Publication Year :: 2018
Publisher :: ELSEVIER SCIENCE INC, 2018.

ISSN :: 14702045
Database :: OpenAIRE
Journal :: The Lancet. Oncology, r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA, instname
Accession number :: edsair.RECOLECTA.....6e39c55cbd715bbeb150b8a075831c3c

Tools